0.00Open0.10Pre Close0 Volume5 Open Interest7.50Strike Price0.00Turnover188.20%IV57.76%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0266Delta0.0075Gamma175.20Leverage Ratio-0.0102Theta-0.0003Rho-4.66Eff Leverage0.0027Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet